IGF1R and neoplasm: Although IGF-IR−/− HSCs do not appear to have overt defects in hematopoietic engraftment and differentiation, the incorporation of IGF-IR−/− hematopoietic cells into the tumor stroma significantly hampered tumor growth and metastasis.